322 related articles for article (PubMed ID: 17366577)
41. Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes.
Tartaglia M; Cotter PD; Zampino G; Gelb BD; Rauen KA
Clin Genet; 2003 May; 63(5):423-6. PubMed ID: 12752577
[TBL] [Abstract][Full Text] [Related]
42. Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.
Tidyman WE; Rauen KA
Methods Mol Biol; 2010; 661():433-47. PubMed ID: 20812000
[TBL] [Abstract][Full Text] [Related]
43. The cardio-facio-cutaneous syndrome: a long-term follow-up of two patients, with special reference to the neurological features.
Sabatino G; Verrotti A; Domizio S; Angeiozzi B; Chiarelli F; Neri G
Childs Nerv Syst; 1997 Apr; 13(4):238-41. PubMed ID: 9202862
[TBL] [Abstract][Full Text] [Related]
44. Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?
Nowaczyk MJ; Thompson BA; Zeesman S; Moog U; Sanchez-Lara PA; Magoulas PL; Falk RE; Hoover-Fong JE; Batista DA; Amudhavalli SM; White SM; Graham GE; Rauen KA
Clin Genet; 2014 Feb; 85(2):138-46. PubMed ID: 23379592
[TBL] [Abstract][Full Text] [Related]
45. Cardio-facio-cutaneous (CFC) syndrome--a distinct entity? Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndrome.
Wieczorek D; Majewski F; Gillessen-Kaesbach G
Clin Genet; 1997 Jul; 52(1):37-46. PubMed ID: 9272711
[TBL] [Abstract][Full Text] [Related]
46. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
[TBL] [Abstract][Full Text] [Related]
47. Prenatal findings in cardio-facio-cutaneous syndrome.
Templin L; Baumann C; Busa T; Heckenroth H; Pouvreau N; Toutain A; Cave H; Verloes A; Sigaudy S; Philip N
Am J Med Genet A; 2016 Feb; 170A(2):441-445. PubMed ID: 26494162
[TBL] [Abstract][Full Text] [Related]
48. Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations.
Rauen KA; Tidyman WE; Estep AL; Sampath S; Peltier HM; Bale SJ; Lacassie Y
Am J Med Genet A; 2010 Apr; 152A(4):807-14. PubMed ID: 20358587
[TBL] [Abstract][Full Text] [Related]
49. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines.
Nishi E; Mizuno S; Nanjo Y; Niihori T; Fukushima Y; Matsubara Y; Aoki Y; Kosho T
Am J Med Genet A; 2015 Feb; 167A(2):407-11. PubMed ID: 25423878
[TBL] [Abstract][Full Text] [Related]
50. HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy.
Estep AL; Tidyman WE; Teitell MA; Cotter PD; Rauen KA
Am J Med Genet A; 2006 Jan; 140(1):8-16. PubMed ID: 16372351
[TBL] [Abstract][Full Text] [Related]
51. LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW.
Morcaldi G; Bellini T; Rossi C; Maghnie M; Boccardo F; Bonioli E; Bellini C
Lymphology; 2015 Sep; 48(3):121-7. PubMed ID: 26939159
[TBL] [Abstract][Full Text] [Related]
52. Fibrous dysplasia in cardio-facio-cutaneous syndrome: A case report and review of literature.
Dong X; Png NCY; Fortier MV; Lim JY; Wong KPL; Choo JTL; Tan EC; Jamuar SS
Am J Med Genet A; 2022 Sep; 188(9):2732-2737. PubMed ID: 35801299
[TBL] [Abstract][Full Text] [Related]
53. Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.
Moriya M; Inoue S; Miyagawa-Tomita S; Nakashima Y; Oba D; Niihori T; Hashi M; Ohnishi H; Kure S; Matsubara Y; Aoki Y
Hum Mol Genet; 2015 Dec; 24(25):7349-60. PubMed ID: 26472072
[TBL] [Abstract][Full Text] [Related]
54. A sibling pair with cardiofaciocutaneous syndrome (CFC) secondary to BRAF mutation with unaffected parents-the first cases of gonadal mosaicism in CFC?
Geoghegan S; King G; Henchliffe J; Ramsden SC; Barry RJ; Green AJ; O'Connell SM
Am J Med Genet A; 2018 Jul; 176(7):1637-1640. PubMed ID: 29704308
[TBL] [Abstract][Full Text] [Related]
55. Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
Aeby A; Sznajer Y; Cavé H; Rebuffat E; Van Coster R; Rigal O; Van Bogaert P
J Inherit Metab Dis; 2007 Oct; 30(5):827. PubMed ID: 17703371
[TBL] [Abstract][Full Text] [Related]
56. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
Seemanová E; Zenker M
Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
[TBL] [Abstract][Full Text] [Related]
57. [Human development and the RAS/MAPK pathway].
Aoki Y; Matsubara Y
Seikagaku; 2007 Jan; 79(1):34-8. PubMed ID: 17319511
[No Abstract] [Full Text] [Related]
58. The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications.
Scorrano G; David E; Calì E; Chimenz R; La Bella S; Di Ludovico A; Di Rosa G; Gitto E; Mankad K; Nardello R; Mangano GD; Leoni C; Ceravolo G
Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136934
[TBL] [Abstract][Full Text] [Related]
59. Ras/MAPK dysregulation in development causes a skeletal myopathy in an activating Braf
Maeda Y; Tidyman WE; Ander BP; Pritchard CA; Rauen KA
Dev Dyn; 2021 Aug; 250(8):1074-1095. PubMed ID: 33522658
[TBL] [Abstract][Full Text] [Related]
60. Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations.
Zenker M; Lehmann K; Schulz AL; Barth H; Hansmann D; Koenig R; Korinthenberg R; Kreiss-Nachtsheim M; Meinecke P; Morlot S; Mundlos S; Quante AS; Raskin S; Schnabel D; Wehner LE; Kratz CP; Horn D; Kutsche K
J Med Genet; 2007 Feb; 44(2):131-5. PubMed ID: 17056636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
